The relationship between sodium intake and mortality: a case-cohort study in a population-based cohort of 148,000 adults with both 24-hour and spot urine samples
Active Project Grant Awarded Last action
- Award ID
- R01HL166509
- Recipient
-
The Leland Stanford Junior University UEI HJD6G4D6TJY5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,899,173
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 88% complete
- Place of performance
- Palo Alto, CA 94305, USA
Award details come from USAspending.gov.
Description
- Abstract
- The largest cohort studies on the subject to date have found that adults with a low estimated sodium intake had a higher risk of mortality than those with a sodium intake close to the population's average. These findings of a "j-shaped" sodium-mortality association have important implications for public health efforts on salt because they suggest that reducing sodium intake at the population level could cause harm among a large proportion of the population. Many investigators have criticized these cohort studies for their use of a spot urine, rather than the gold-standard 24-hour urine sample, to estimate sodium intake. Thus far, however, the debate on the shape of the sodium-mortality association could not be settled convincingly because analyses of cohort studies that collected 24-hour urine samples have suffered from far smaller sample sizes than of those that collected a spot urine. The overall objective of this project is to better understand the association of sodium intake with mortality, particularly at levels of sodium intake below the population average in the US. The central hypothesis is that the j-shape of the sodium-mortality association that has been reported by some investigators is a result of bias from assessing sodium intake through use of a spot rather than a 24-hour urine sample. This central hypothesis will be tested by pursuing three specific aims: 1) determine the range of sodium intake among adults that is associated with the lowest risk of all-cause mortality; 2) determine whether the commonly reported increased risk of mortality at low levels of sodium intake stems from using a spot urine (rather than the gold-standard 24-hour urine) to estimate 24-hour sodium intake; and 3) establish whether the association of sodium intake with cardiovascular causes of death is the main determinant of the shape of the sodium-mortality association. Using a case-cohort design, this project will analyze the sodium and potassium concentration in urine samples collected as part of lifelines, which is a population-based cohort study focused on healthy aging in the northern netherlands. The lifelines cohort has three unique features that enable the investigators to make an important contribution to resolving the controversy about the j-shaped sodium- mortality association: 1) lifelines has collected two 24-hour urine samples from its participants; 2) with 147,888 adult participants and over 6,000 deaths (over a 15-year follow-up period), the lifelines cohort has a far larger sample size and number of deaths than any other cohorts that have collected 24-hour urine samples; and 3) lifelines has additionally collected a spot urine sample from all participants such that we are able to directly compare the shape of the sodium-mortality association depending on whether a spot or the gold-standard 24- hour urine sample is used. This project is significant because IT will inform dietary guidelines on salt, and whether public health efforts should attempt to lower sodium intake among the entire population (e.g., through reformulation of the food supply) or focus instead only on individuals who consume high levels of sodium.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $36,206 | |
| Amendment | $496,751 | |
| Amendment | $68,771 | |
| Amendment | $68,771 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $504,959 | |
| Amendment | $504,959 | |
| Amendment | $41,077 | |
| Amendment | $462,113 | |
| Amendment | $462,113 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $545,743 | |
| Amendment | $545,743 | |
| Amendment | $545,743 | |
| Original award | $545,743 |
Show all 22
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Medische Biobank Noord-Nederland B.V. | $68,771 | |
| The Administrators Of Tulane Educational Fund | $27,923 | |
| The Administrators Of Tulane Educational Fund | $35,352 | |
| Medische Biobank Noord-Nederland B.V. | $137,541 | |
| Brigham & Womens Hospital Inc. | $32,108 | |
| The Administrators Of Tulane Educational Fund | $27,298 |
Quick answers
Who received award R01HL166509?
R01HL166509 was awarded to The Leland Stanford Junior University by National Heart Lung and Blood Institute (National Institutes of Health) on August 23, 2023.
How much is award R01HL166509 worth?
$5,899,173 has been obligated on R01HL166509.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award